• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchCohBar
    Picture of CohBar logo

    CWBR — CohBar News Story

    $0.410.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    • Market Cap
      $1.19m
    • Enterprise Value
      -$11.12m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • CWBR Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    CWBR Dividends
    All News

    NASDAQ RESUMED AT 10:18 AM

    Picture of CohBar logoCohBar
    28/02/2020 15:18
    NASDAQ RESUMED  CWBR.O  AT 10:18 AM
    

    Recent news on CohBar

    See all news
    • Brief: CohBar, Inc. Q2 EPS USD -1.49

      14/08/2023 22:12
    • Brief: Morphogenesis And CohBar Announce Positive Results From Phase 1B Trial Of IFX-HU2.0 Personalized Cancer Vaccine, In Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) And Cutaneous Squamous Cell Carcinoma (CSCC)

      05/06/2023 16:17
    • U.S. STOCKS ON THE MOVE-Galecto, Pinterest, Standard Lithium

      23/05/2023 19:04
    • CohBar surges on merger agreement with Morphogenesis

      23/05/2023 17:32
    • U.S. STOCKS ON THE MOVE-Chevron, Broadcom, Williams-Sonoma

      23/05/2023 16:59

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.